Matthews Group
megamatthewslab.bsky.social
Matthews Group
@megamatthewslab.bsky.social
Chemical Biology
1/14 Our latest study just out on BioRxiv [https://www.biorxiv.org/content/10.1101/2024.12.19.629450] has unusual personal significance for me. It connects two apparently unrelated diseases – (pre)eclampsia and glioblastoma – that have both impacted my family.
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastoma https://www.biorxiv.org/content/10.1101/2024.12.19.629450v1
January 1, 2025 at 7:15 PM